Pfizer (PFE)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-03 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: PFIZER INC (PFE) CIK: 0000078003 --- Reporting Owner --- Name: BOURLA ALBERT CIK: 0001595703 Role: Director, Officer (Chairman & CEO) --- Derivative Transactions --- [Transaction #1] Security: Stock Appreciation Rights Date: 2026-03-03 | Code: A (Grant or award) Shares: +708,666 | Price: $0.00 Exercisable: N/A | Expires: 2031-03-03 Shares Owned After: 708,666 | Ownership: D (Direct) Footnotes: [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. --- Footnotes (Complete Index) --- F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. --- Signature --- /s/ /s/ Shanice A. Reid, by power of atty., for Albert Bourla (2026-03-05)